This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.

Clinical Outcomes of Early Versus Delayed Management of Iraqi Patients With Rheumatoid Arthritis With Etanercept

This study is to investigate the effect of etanercept in early versus delayed referral for management of rheumatoid arthritis patients assessing real-world patient data entered in the Iraq National Center of Rheumatology database between May 2012 and May 2017.

Inclusion Criteria:

• Diagnosed RA patients.
• 18 years old and above.
• Did not receive pervious biological treatment.

Exclusion Criteria:

• Had previous biological treatment
• Use etanercept for less than 1 year